✦ LIBER ✦

Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes

✍ Scribed by Constantin N. Baxevanis; Michael Papamichail

Book ID: 105966760
Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 347 KB
Volume: 53
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-004-0523-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting of GD2-positive tumor cells by

Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

✍ Claudia Rossig; Catherine M. Bollard; Jed G. Nuchtern; Durriya A. Merchant; Malc 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 241 KB 👁 1 views

Genetic engineering of human T lymphocytes to express tumor antigen-specific chimeric immune receptors is an attractive means for providing large numbers of effector cells for adoptive immunotherapy while bypassing major mechanisms of tumor escape from immune recognition. We have applied this strate

Pharmacologic suppression of target cell

Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors

✍ Álvarez-Vallina, Luis; Yañez, Rosa; Blanco, Belén; Gil, Magdalena; Russell, Step 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Tissue-Specific, Cell Cycle-Regulated Ch

Tissue-Specific, Cell Cycle-Regulated Chimeric Transcription Factors for the Targeting of Gene Expression to Tumor Cells

✍ Jérôme, Valérie; Müller, Rolf 📂 Article 📅 1998 🏛 Mary Ann Liebert 🌐 English ⚖ 572 KB

T cell targeting of TAG72+ tumor cells b

T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope

✍ A Hombach; C Heuser; R Sircar; T Tillmann; V Diehl; W Kruis; C Pohl; H Abken 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Therapeutic effectiveness of the immunit

Therapeutic effectiveness of the immunity elicited by P815 tumor cells engineered to express the B7-2 costimulatory molecule

✍ Ross N. La Motte; Michael A. Rubin; Eliav Barr; Jeffrey M. Leiden; Jeffrey A. Bl 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

Presentation of native TROP-2 tumor anti

Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells

✍ Giorgio Mangino; Maria Grazia Capri; Vincenzo Barnaba; Saverio Alberti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 189 KB 👁 1 views

Professional antigen-presenting cells (APC), e.g. dendritic cells, express immuno-proteasome components and process proteins for MHC presentation differently from non-immune cells. Thus, they induce reactivities against sets of peptides that do not overlap with those generated by non-professional AP